These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 25689415

  • 1. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 2. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 3. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
    Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J.
    Behav Brain Res; 2016 Oct 15; 313():334-344. PubMed ID: 27424778
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.
    Shoshan N, Segev A, Abush H, Mizrachi Zer-Aviv T, Akirav I.
    Hippocampus; 2017 Oct 15; 27(10):1093-1109. PubMed ID: 28667676
    [Abstract] [Full Text] [Related]

  • 5. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec 15; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 6. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 15; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 7. Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats.
    De Carvalho CR, Pamplona FA, Cruz JS, Takahashi RN.
    Psychopharmacology (Berl); 2014 Apr 15; 231(7):1417-25. PubMed ID: 24247477
    [Abstract] [Full Text] [Related]

  • 8. Examination of the effects of cannabinoid ligands on decision making in a rat gambling task.
    Ferland JN, Carr MR, Lee AM, Hoogeland ME, Winstanley CA, Pattij T.
    Pharmacol Biochem Behav; 2018 Jul 15; 170():87-97. PubMed ID: 29787777
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats.
    Hlavacova N, Chmelova M, Danevova V, Csanova A, Jezova D.
    Endocr Regul; 2015 Jul 15; 49(3):131-6. PubMed ID: 26238495
    [Abstract] [Full Text] [Related]

  • 10. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May 15; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

  • 11. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA, Xu Z, Mali SS, Hohmann AG.
    Pharmacol Res; 2019 Apr 15; 142():267-282. PubMed ID: 30739035
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE, Miller F, Palchik G, Deadwyler SA.
    Neuropharmacology; 2011 May 15; 60(6):944-52. PubMed ID: 21288475
    [Abstract] [Full Text] [Related]

  • 13. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan 15; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 14. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
    Vimalanathan A, Gidyk DC, Diwan M, Gouveia FV, Lipsman N, Giacobbe P, Nobrega JN, Hamani C.
    Neuropharmacology; 2020 Apr 15; 166():107965. PubMed ID: 31962287
    [Abstract] [Full Text] [Related]

  • 15. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
    Gomes FV, Casarotto PC, Resstel LB, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):434-8. PubMed ID: 21111767
    [Abstract] [Full Text] [Related]

  • 16. Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats.
    Hasanein P, Ghafari-Vahed M.
    Behav Pharmacol; 2016 Feb 30; 27(1):37-43. PubMed ID: 26274041
    [Abstract] [Full Text] [Related]

  • 17. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
    Su SH, Wu YF, Lin Q, Hai J.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec 30; 390(12):1189-1200. PubMed ID: 28825114
    [Abstract] [Full Text] [Related]

  • 18. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC, Bermúdez-Silva FJ, Malinen H, Hyytiä P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M.
    Neuropsychopharmacology; 2007 Jan 30; 32(1):117-26. PubMed ID: 16482090
    [Abstract] [Full Text] [Related]

  • 19. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
    Bambico FR, Duranti A, Nobrega JN, Gobbi G.
    Eur Neuropsychopharmacol; 2016 Mar 30; 26(3):578-90. PubMed ID: 26747370
    [Abstract] [Full Text] [Related]

  • 20. Bidirectional cannabinoid modulation of social behavior in adolescent rats.
    Trezza V, Vanderschuren LJ.
    Psychopharmacology (Berl); 2008 Apr 30; 197(2):217-27. PubMed ID: 18058088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.